FMS Fresenius Medical Care AG Загрузка...

Загрузка графика...
Лучшие сигналы
Лента
Загрузка...
Загрузка...
Загрузка...
Загрузка...
Загрузка...
Загрузка...
0 выбрано
Весь контент✓
Ленты источников
Buzzberg Топ 50 ✓
Все капитализацииБез фильтра по капитализации✓
200 млрд и вышеМега✓
от 10 до 200 млрдКрупные✓
от 2 до 10 млрдСредние✓
от 0 до 2 млрдМалые✓
Свой
Введите диапазон капитализации в млрд USD
Все направления✓
▲ Лонг✓
▼ Шорт✓
⛔ Избегать✓
✂ Закрытие✓
◦ Другие✓
Любая оценка✓
Низкая+✓
Средняя+✓
Высокая✓
? ?
13:58
06 авг
Chamath Palihapitiya Генеральный директор, Social Capital Chamath Palihapitiya
Article names Fresenius as the other largest dialysis operator hit by about 17% after kidney outcomes, implying similar revenue pressure from a smaller kidney-failure population.
Article names Fresenius as the other largest dialysis operator hit by about 17% after kidney outcomes, implying similar revenue pressure from a smaller kidney-failure population. Risk: Fresenius Medical Care's international mix and non-dialysis businesses may reduce the overall impact.
FMS
21:00
04 авг ◎
Joel Ackerman CFO, DaVita Inc. DVA Q2 FY26 call
DaVita's treatment volume growth is being driven almost entirely by reduced mortality, not new patient starts, and it is outperforming the industry's negative same-store growth. — This confirms DaVita is gaining market share through superior clinical outcomes, a trend that could pressure competitors who cannot replicate the mortality improvements.
FMS
Выс.
21:55
03 авг
Bloomberg Newswire (@business)
Fresenius Medical Care reports second-quarter profit above expectations driven by strong.
Fresenius Medical Care reports second-quarter profit above expectations driven by strong dialysis service unit performance.
FMS
12:11
28 июл
DeItaone Агрегатор новостей Twitter (Walter Bloomberg)
UBS, Stephens, Jefferies, Exane BNP Paribas, TD Cowen, Morgan Stanley, Wells Fargo.
UBS, Stephens, Jefferies, Exane BNP Paribas, TD Cowen, Morgan Stanley, Wells Fargo, Raymond James, and BMO downgraded multiple stocks including ACI, BLFS, CLX, FMS, INSP, INTU, LAUR, LEVI, MPLT, PINE, RXO, SIGI, and XOM with various price target cuts.
FMS
11:52
28 июл
DeItaone Агрегатор новостей Twitter (Walter Bloomberg)
Goldman Sachs upgrades CIB to Buy, KeyBanc upgrades FLY to Overweight.
Goldman Sachs upgrades CIB to Buy, KeyBanc upgrades FLY to Overweight, and multiple other analyst upgrades and downgrades are reported across a wide range of stocks with specific price target changes.
FMS
08:30
23 июл ◎
Jim Davis DGX Q2 FY26 call
Quest's partnership with Fresenius is driving volume and expanding its kidney testing portfolio, contributing to revenue growth.
FMS
Выс.
21:00
05 мая ◎
Javier Rodriguez DVA Q1 FY26 call
DaVita expects to gain dialysis patients from Fresenius clinic closures, with half arriving in Q1 and most of the rest in Q2, contributing positively to 2026 volume growth. — Fresenius's network rationalization is ceding market share to DaVita, a direct transfer of volume and revenue.
FMS
Выс.
08:30
21 апр ◎
Sam Samad DGX Q1 FY26 call
Quest provides lab testing for Fresenius dialysis clinics; this relationship contributes significantly to volume but has a dilutive effect on revenue per requisition.
FMS
Выс.
08:30
10 фев ◎
Jim Davis DGX Q4 FY25 call
Quest has scaled operations for Fresenius, indicating strong demand for dialysis testing services; Fresenius benefits from Quest's expanded capacity and water purity testing.
FMS
Выс.
08:30
21 окт ◎
Jim Davis DGX Q3 FY25 call
Quest has won a large enterprise agreement to serve Fresenius dialysis centers, adding revenue and utilizing excess capacity.
FMS
Выс.

Об аналитическом покрытии FMS

Buzzberg отслеживает FMS (Fresenius Medical Care AG) в 4 источниках. Бычьих сигналов: 0, медвежьих: 0, от 7 аналитиков. Сентимент разделён поровну. Всего отслеживается 10 торговых идей. Последние спикеры: Chamath Palihapitiya, Joel Ackerman, Bloomberg.